Seven innovative lung health research projects have received funding support as the 2023 Wal-yan Respiratory Research Centre Strategic Inspiration Pr…
Despite their increasing popularity, and Australia's unique regulatory environment, how and why Australian adults use e-cigarettes and their percepti…
Our Children’s Respiratory Science team is currently seeking research buddies to provide a community perspective on research into childhood asthma at…
Cystic fibrosis (CF) is a rare, inherited, life-limiting condition predominantly affecting the lungs, for which there is no cure. The disease is char…
Addressing the recognized challenges and inequalities in providing high quality healthcare for rare diseases such as children's interstitial lung dis…
Structural lung disease and neutrophil-dominated airway inflammation is present from 3 months of age in children diagnosed with cystic fibrosis after…
This position statement, updated from the 2015 guidelines for managing Australian and New Zealand children/adolescents and adults with chronic suppur…
A population of neutrophils recruited into cystic fibrosis (CF) airways is associated with proteolytic lung damage, exhibiting high expression of pri…
More than 14 researchers from the Wal-yan Respiratory Research Centre will be welcomed as presenters and facilitators at The Thoracic Society of Aust…
WA researchers will use a $1.97 million Medical Research Future Fund grant to develop a strategy for better follow-up of First Nations children after…